Oragenics Reports Clinical Advancements and NYSE American Listing Status

Oragenics provided an update on its ongoing clinical trials while confirming its continued compliance and listing status on the NYSE American exchange.

28 Aug, 20:25 — 28 Aug, 20:25

Post Share

Sources

Showing 1 of 1 sources

taiwan-newsMostly Factual9d ago

Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update - Taiwan News

Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update Taiwan News

Read full article →

Oragenics Reports Clinical Advancements and NYSE American Listing Status

Sources

Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update - Taiwan News

Related Stories

Media Coverage Highlights Exiled Russian Journalists and Tech Influence

Volkswagen to Sell Osnabrück Plant and Pivot Toward Defense Manufacturing

UK Chancellor Healey Outlines Fiscal Discipline and Regional Growth Strategy

Jaguar Land Rover to Cut 4,000 Jobs in Global Restructuring Plan